January 28, 2019
Spiro Rombotis and Paul McBarron of Cyclacel Pharmaceuticals discuss the company's pipeline, indications, clinical data and more.
October 21, 2018
MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 7, 2018
vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
September 10, 2018
Cyclacel Pharmaceuticals (Nasdaq:CYCC, Nasdaq:CYCCP) a biopharmaceutical company developing innovative medicines based on cancer biology, announced the initiation of a Phase...